ACITRETIN
Generic: ACITRETIN
Alembic Pharmaceuticals Inc.Manufacturer
ORALRoute
ACITRETINActive Substance
2024-08-05Original Approval
ACITRETIN is FDA application ANDA217774, sponsored by ALEMBIC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
PSORIASIS
1,184 reports
2
DRUG INEFFECTIVE
1,170 reports
3
PAIN
490 reports
4
FATIGUE
483 reports
5
OFF LABEL USE
476 reports
6
NAUSEA
441 reports
7
PRURITUS
441 reports
8
HEADACHE
372 reports
9
SKIN EXFOLIATION
372 reports
10
PNEUMONIA
357 reports